With that in mind, let's consider two stocks down 17% and 36%, respectively, this year that are worth investing in right now: ...

The Cleburne Railroaders hosted their first taste of baseball at La Moderna Field with exhibition games between the Charros ...

Jenny Strasburg is a reporter in London, where she writes for The Wall Street Journal about oil and gas, climate, the ...

James Willhite was an editor with The Wall Street Journal's money & investing team based in London.

Nearly a year and a half after Covid vaccines became available to adults in the U.S., the FDA has authorized two vaccines for ...

The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.

On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in ...

The United States is already falling behind China in countless technological advancements, thanks to several Biden-era policies.

Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company ...

Moderna MRNA is expected to report first-quarter 2025 earnings on May 1, before the opening bell. The company’s earnings beat ...

BofA lowered the firm’s price target on Moderna (MRNA) to $26 from $32 and keeps an Underperform rating on the shares. For 2025, the firm’s ...

CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA ...